Adult T-cell Leukemia/Lymphoma

This book provides essential information on the epidemiology, molecular and genetic features, anti-CCR4 antibody therapy and a nationwide study of transplantation on human T-leukemia virus type-I (HTLV-1) and adult T-cell leukemia/lymphoma (ATL). This rare but important disease has restricted endemi...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Watanabe, Toshiki (Επιμελητής έκδοσης), Fukushima, Takuya (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Tokyo : Springer Japan : Imprint: Springer, 2017.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 02564nam a22004815i 4500
001 978-4-431-56523-9
003 DE-He213
005 20170427171702.0
007 cr nn 008mamaa
008 170427s2017 ja | s |||| 0|eng d
020 |a 9784431565239  |9 978-4-431-56523-9 
024 7 |a 10.1007/978-4-431-56523-9  |2 doi 
040 |d GrThAP 
050 4 |a RB45 
072 7 |a MJF  |2 bicssc 
072 7 |a MED038000  |2 bisacsh 
082 0 4 |a 616.15  |2 23 
245 1 0 |a Adult T-cell Leukemia/Lymphoma  |h [electronic resource] /  |c edited by Toshiki Watanabe, Takuya Fukushima. 
264 1 |a Tokyo :  |b Springer Japan :  |b Imprint: Springer,  |c 2017. 
300 |a VIII, 169 p. 41 illus., 26 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
520 |a This book provides essential information on the epidemiology, molecular and genetic features, anti-CCR4 antibody therapy and a nationwide study of transplantation on human T-leukemia virus type-I (HTLV-1) and adult T-cell leukemia/lymphoma (ATL). This rare but important disease has restricted endemic areas and distinct clinical features such as a high frequency of hypercalcemia, strong predisposition to infection and poor response to chemotherapy, aspects which set ATL apart from other types of non-Hodgkin lymphoma. Given the small number of patients, enrollment in clinical trials has not been feasible, and establishing treatment standard has been difficult but new evidence, such as results of nationwide studies on transplantation, have shown new insights and potential treatments. Based on recent evidence, the book presents new treatment methods for ATL and infection prevention of HTLV-1, enabling clinicians, researchers and post-docs specializing in hematology and virology to gain a valuable overview of the disease. 
650 0 |a Medicine. 
650 0 |a Immunology. 
650 0 |a Hematology. 
650 0 |a Infectious diseases. 
650 0 |a Oncology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Hematology. 
650 2 4 |a Oncology. 
650 2 4 |a Infectious Diseases. 
650 2 4 |a Immunology. 
700 1 |a Watanabe, Toshiki.  |e editor. 
700 1 |a Fukushima, Takuya.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9784431565215 
856 4 0 |u http://dx.doi.org/10.1007/978-4-431-56523-9  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)